These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 25824305)

  • 41. Childhood trauma, BDNF Val66Met and subclinical psychotic experiences. Attempt at replication in two independent samples.
    de Castro-Catala M; van Nierop M; Barrantes-Vidal N; Cristóbal-Narváez P; Sheinbaum T; Kwapil TR; Peña E; Jacobs N; Derom C; Thiery E; van Os J; van Winkel R; Rosa A
    J Psychiatr Res; 2016 Dec; 83():121-129. PubMed ID: 27596955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The BDNF Val66Met polymorphism and smoking.
    Montag C; Basten U; Stelzel C; Fiebach CJ; Reuter M
    Neurosci Lett; 2008 Sep; 442(1):30-3. PubMed ID: 18602452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study.
    Montag C; Reuter M; Newport B; Elger C; Weber B
    Neuroimage; 2008 Oct; 42(4):1554-9. PubMed ID: 18603005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.
    Kanazawa T; Glatt SJ; Kia-Keating B; Yoneda H; Tsuang MT
    Psychiatr Genet; 2007 Jun; 17(3):165-70. PubMed ID: 17417060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial.
    Grande I; Magalhães PV; Chendo I; Stertz L; Fries GR; Cereser KM; Cunha ÂB; Gói P; Kunz M; Udina M; Martín-Santos R; Frey BN; Vieta E; Kapczinski F
    Acta Psychiatr Scand; 2014 May; 129(5):393-400. PubMed ID: 23957567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
    Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
    Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Food restriction leads to binge eating dependent upon the effect of the brain-derived neurotrophic factor Val66Met polymorphism.
    Akkermann K; Hiio K; Villa I; Harro J
    Psychiatry Res; 2011 Jan; 185(1-2):39-43. PubMed ID: 20537407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli.
    van Wingen G; Rijpkema M; Franke B; van Eijndhoven P; Tendolkar I; Verkes RJ; Buitelaar J; Fernández G
    Neuroimage; 2010 Apr; 50(3):1212-8. PubMed ID: 20097294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BDNF Val66Met polymorphism and bipolar disorder in European populations: A risk association in case-control, family-based and GWAS studies.
    Li M; Chang H; Xiao X
    Neurosci Biobehav Rev; 2016 Sep; 68():218-233. PubMed ID: 27236043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Brain-derived neurotrophic factor: from nerve growth factor to modulator of brain plasticity in cognitive processes and psychiatric diseases].
    Laske C; Eschweiler GW
    Nervenarzt; 2006 May; 77(5):523-37. PubMed ID: 16078056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No major clinical impact of Val66Met BDNF gene polymorphism on temporal lobe epilepsy.
    Bragatti JA; Schenkel LC; Torres CM; Manfro GG; Blaya C; Souza AC; Souza DO; Saraiva-Pereira ML; Jardim LB; Leistner-Segal S; Bianchin MM
    Epilepsy Res; 2010 Feb; 88(2-3):108-11. PubMed ID: 19896331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BDNF Val66Met variant and age of onset in schizophrenia.
    Chao HM; Kao HT; Porton B
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):505-6. PubMed ID: 17894414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol.
    Vinberg M; Trajkovska V; Bennike B; Knorr U; Knudsen GM; Kessing LV
    Psychoneuroendocrinology; 2009 Oct; 34(9):1380-9. PubMed ID: 19473771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between BDNF Val66Met polymorphism and generalized anxiety disorder and clinical characteristics in a Mexican population: A case-control study.
    González-Castro TB; Pool-García S; Tovilla-Zárate CA; Juárez-Rojop IE; López-Narváez ML; Frésan A; Genis-Mendoza AD; Pérez-Hernández N; Nicolini H
    Medicine (Baltimore); 2019 Mar; 98(11):e14838. PubMed ID: 30882674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain Derived Neurotrophic Factor (BDNF) levels as a possible predictor of psychopathology in healthy twins at high and low risk for affective disorder.
    Vinberg M; Miskowiak K; Kessing LV
    Psychoneuroendocrinology; 2014 Jan; 39():179-183. PubMed ID: 24112874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary study of anxiety symptoms, family dysfunction, and the brain-derived neurotrophic factor (BDNF) Val66Met genotype in offspring of parents with bipolar disorder.
    Park MH; Chang KD; Hallmayer J; Howe ME; Kim E; Hong SC; Singh MK
    J Psychiatr Res; 2015 Feb; 61():81-8. PubMed ID: 25498133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder.
    Moreira FP; Fabião JD; Bittencourt G; Wiener CD; Jansen K; Oses JP; Quevedo Lde Á; Souza LD; Crispim D; Portela LV; Pinheiro RT; Lara DR; Kaster MP; da Silva RA; Ghisleni G
    Psychiatr Genet; 2015 Oct; 25(5):201-7. PubMed ID: 26110341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BDNF Val66Met polymorphism is not related with temporal lobe epilepsy caused by hippocampal sclerosis in Brazilian population.
    Alcantara JA; Vincentiis S; Santos B; Kerr D; de Paula V; Alessi R; Linden H; Chaim T; Serpa M; Busatto G; Gattaz W; Valente KD
    Seizure; 2018 Aug; 60():159-162. PubMed ID: 30015148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The BDNF Val66Met polymorphism enhances glutamatergic transmission but diminishes activity-dependent synaptic plasticity in the dorsolateral striatum.
    Jing D; Lee FS; Ninan I
    Neuropharmacology; 2017 Jan; 112(Pt A):84-93. PubMed ID: 27378336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.